Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Titel:
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
Auteur:
Merola, Joseph F Landewé, Robert McInnes, Iain B Mease, Philip J Ritchlin, Christopher T Tanaka, Yoshiya Asahina, Akihiko Behrens, Frank Gladman, Dafna D Gossec, Laure Gottlieb, Alice B Thaçi, Diamant Warren, Richard B Ink, Barbara Assudani, Deepak Bajracharya, Rajan Shende, Vishvesh Coarse, Jason Coates, Laura C
Verschenen in:
Lancet
Paginering:
Jaargang 401 () nr. 10370 pagina's 38-48
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license